News on DNA library prep, labeling, extraction, automation, protein purification & enrichment in genetics, genomics, and molecular diagnostics.
The company's technology uses CRISPR to deplete unwanted nucleic acid sequences from NGS libraries, leaving behind targets of interest.
Shares of Illumina fell in afternoon trading on the Nasdaq following a brief rise after the market open.
The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.
The agency is providing the material freely and asking for feedback, so it can fix possible problems before more widely disseminating it to labs and companies.
The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share.
